Transforming your Assets & Facility to Enhance
Innovations and Cost Optimisation

As the industry undergoes transformation, streamlined operations and implementing digital solutions are front of mind for our community. Capturing current asset and facility management priorities among lab and manufacturing leaders in the pharma and biotech sector, Critical Assets & Facility Management in Pharma Summit will help you optimize capital expenditure while enhancing productivity through innovative technology and strategic thinking.

CAFM 2020 will help you regain control of inventory management, mitigate risk through bolstering your asset reliability and maintenance strategy, extend and manage asset lifecycles and help you reach your sustainability goals.

The 3-day agenda is designed to help spark conversations and provide you with practical takeaways, hearing from names such as GSK, Seattle Genetics, Regeneron and Sanofi. This event is dedicated to exploring strategies in the lab and manufacturing environment, where you will join 60 senior experts from functions of Asset Management, Facility Management, Lab and Manufacturing Operations, Engineering, Procurement and Energy and Sustainability across pharma, biotech and CMOs/CROs.

This is your one and only industry-led meeting in this space. Don’t miss out on this unique meeting to engage with your peers and re-define best practice for tomorrow’s 24/7 operations!

It's free to attend for Pharma, Biotech, CMOs/CROs . We're operating with limited capacity so secure your place quick!

'We really enjoyed the event. The subject has huge potential as pressures continue to drive different ways of managing lab assets and environments.'

- iLS Group Director 


The speakers were outstanding and topics were very relevant! The vendors were innovative! Great job with a packed agenda! 

- Director, Facilities Operations of America & APAC,

Bio-Rad Laboratories

Very engaging and open participants. Virtualy every presentation had a nugget of wisdom that holds potential for implementation at my organization!

- Group Director, R&D Business Operations

Bristol-Myers Squibb